Neurology News

Cerebrospinal fluid diversion was not associated with improved outcome for children following a traumatic brain injury. However, a decrease in intracranial pressure was observed, researchers reported in JAMA Network Open.

Dementia cases in the United States were largely associated with modifiable risk factors, such as hypertension, obesity and physical inactivity — especially among Black and Hispanic people, researchers reported in JAMA Network Open.

Transdermal CBD was well tolerated and safe among those with drug-resistant focal epilepsy, although no efficacy was observed compared with placebo during a 12-week treatment period, researchers reported in JAMA Network Open.

Postmenopausal women had a greater burden of white matter hyperintensity — or WMH — compared with men and premenopausal women, as well as a faster increase in WMH, according to a cross-sectional analysis of the Rhineland Study.

Oral contraceptive use and hormone therapy were associated with an increased risk for stroke, according to study findings published in Stroke.

CHARLOTTE, N.C. — Higher sleep scores were associated with lower mortality hazard, according to a study presented at the SLEEP 2022 meeting.

The NIH has awarded researchers at the University of Illinois Urbana-Champaign more than $420,000 to develop ultrasound imaging methods to study neurovascular changes underlying Alzheimer’s disease.

In this week’s edition, women are less likely than men to return to work after large vessel occlusion stroke; cognitive impairment, headaches and CVD are more common in former college football players; veterans, providers support the addition of integrative medicine for chronic headaches; and more.

The American Academy of Neurology, along with the American Epilepsy Society and the Society for Maternal-Fetal Medicine, has provided a practice guidance update for women with epilepsy of childbearing potential.

While well tolerated, balovaptan did not improve socialization and communication difficulties in young persons with autism spectrum disorder compared with placebo, according to results of a clinical trial published in JAMA Psychiatry.